MedAvail(OTC) MDVLQ

Market Cap$200.00

Since IPO (2020)-100%

5 Year-100%

1 Year+0%

1 Month+0%

$0.00

+0%

+0.00Today

MedAvail last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-06-23

MedAvail stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-06-15
1 month	+0%	USD 0.00	2026-05-22
3 month	+0%	USD 0.00	2026-03-16
Year to date	+0%	USD 0.00	2025-12-24
1 year	+0%	USD 0.00	2025-06-20
3 year	-100%	USD 13.45	2023-06-23
5 year	-100%	USD 710.00	2021-06-24
Since inception	-100%	USD 450.00	2020-11-19

MedAvail Financials at a Glance

Market Cap

$200.00

Revenue (TTM)

$23.84M

Net Income (TTM)

-$46.00M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

26313.68 (High)

Dividend

$0.00

Beta (Volatility)

26313.68 (High)

Price

$0.00

Volume

Open

$0.00

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.05

Estimated Earnings Date

May 29, 2026

Dividend

$0.00

Beta (Volatility)

26313.68 (High)

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.05

Estimated Earnings Date

May 29, 2026

MDVLQ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About MedAvail

MedAvail Holdings, Inc. is a technology-driven provider of retail pharmacy services and solutions in the United States and Canada. The company specializes in self-service pharmacy systems, mobile applications, and kiosk-based solutions, with a focus on enhancing medication access.

Products and Services

MedAvail MedCenter for on-site prescription dispensing
Mobile applications for pharmacy management
Kiosk-based solutions for retail and clinical environments

Growth Outlook

Recent quarterly revenue of $405,000 shows potential for recovery
Cash and cash equivalents of $15 million provide operational flexibility
Current ratio of 4.03 indicates strong short-term financial health

Financial Highlights

Trailing twelve months revenue of $1.03 million reflects ongoing challenges
Net income for Q2 2023 was -$5.79 million, indicating losses
Operating expenses of $4.63 million in Q2 2023 highlight cost management needs

MedAvail Holdings, Inc. operates in the healthcare sector, focusing on innovative pharmacy solutions. The MedAvail MedCenter is a key offering, allowing for real-time pharmacist consultations during medication dispensing. Despite recent financial challenges, the company maintains a significant cash position, which may support future growth initiatives. The current ratio suggests that MedAvail is well-positioned to meet short-term obligations, although ongoing operational losses indicate a need for strategic adjustments. Investors may find the company's technology-driven approach and market potential noteworthy as it navigates its financial landscape.

AI Generated • Jul 20, 2026

Industry

Food and Staples Retailing

Sector

Consumer Staples

Employees

279

CEO

Mark Doerr

Website

medavail.com

Headquarters

Phoenix, AZ 85040, US

MDVLQ Financials

Key Financial Metrics (TTM)

Gross Margin

6.00%

Operating Margin

-107.69%

Net Income Margin

-110.45%

Return on Equity

-238.69%

Return on Capital

-166.39%

Return on Assets

-143.72%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$200.00

Shares Outstanding

1.61M

Volume

Avg. Volume

3.887

Financials (TTM)

Gross Profit

$221.00K

Operating Income

-$31.70M

EBITDA

-$35.23M

Operating Cash Flow

-$31.54M

Capital Expenditure

-$692.00K

Free Cash Flow

-$32.23M

Cash & ST Invst.

$15.04M

Total Debt

$2.26M

MedAvail Performance Analysis

MedAvail annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2021	2021-12-31	USD 22,129,000	N/A
2022	2022-12-31	USD 43,109,000	94.8%

MedAvail sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2022-09-30	2.5%
Q4	2022-12-31	-1.0%
Q1	2023-03-31	-94.5%
Q2	2023-06-30	-34.7%

MedAvail annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2021	2021-12-31	USD -67.09	N/A
2022	2022-12-31	USD -36.20	-46.0%

MedAvail sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2022-09-30	12.8%
Q4	2022-12-31	6.2%
Q1	2023-03-31	-56.2%
Q2	2023-06-30	70.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2023YOY CHG

Revenue

$405.00K

-96.4%

Gross Profit

$178.00K

-64.8%

Gross Margin

43.95%

N/A

Market Cap

$200.00

N/A

Market Cap/Employee

$0.72

N/A

Employees

279

N/A

Net Income

-$5.79M

+50.6%

EBITDA

-$4.92M

-10.6%

Quarterly Fundamentals

Name

Q2 2023YOY CHG

Total Cash

$15.04M

-49.7%

Total Debt

$2.26M

-81.7%

Accounts Receivable

$292.00K

-85.9%

Inventory

$10.07M

+79.1%

Long Term Debt

$2.06M

-82.3%

Short Term Debt

$208.00K

-72.0%

Return on Assets

-1.44%

N/A

Return on Invested Capital

-1.71%

N/A

Free Cash Flow

-$4.47M

+66.4%

Operating Cash Flow

-$4.38M

+64.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

HTGMQHTG Molecular Diagnostics, Inc.

HTGMQHTG Molecular Diagnostics, Inc.$0.00+0.00%

NEXINexImmune, Inc.

NEXINexImmune, Inc.$0.00+0.00%

BIOCQBiocept, Inc.

BIOCQBiocept, Inc.$0.00+0.00%

BSPMBiostar Pharmaceuticals, Inc.

BSPMBiostar Pharmaceuticals, Inc.$0.00+0.00%

OMDDOrmand Industries Inc

OMDDOrmand Industries Inc$0.00+0.00%

NBRVFNabriva Therapeutics plc

NBRVFNabriva Therapeutics plc$0.00+0.00%

NMSCANutrition Management Services Company

NMSCANutrition Management Services Company$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares

MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares$19.63-0.20%

SKHYSK Hynix

SKHYSK Hynix$126.79-0.03%

NOKNokia

NOKNokia$8.41-0.06%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$57.75-0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$6.74-0.06%

INTCIntel

INTCIntel$81.88-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$49.44+0.06%

Questions About MDVLQ

What is the current price of MedAvail?

MedAvail is trading at $0.00 per share.

What is the 52-week range for MedAvail?

Over the past 52 weeks, MedAvail has traded between $0.00 and $0.05.

How much debt does MedAvail have?

As of the most recent reporting period, MedAvail reported total debt of $7.08M.

How much cash does MedAvail have on hand?

MedAvail reported $12.12M in cash and cash equivalents in its most recent financial results.

What is MedAvail’s dividend yield?

MedAvail does not currently have a dividend yield.

MedAvail(OTC) MDVLQ

MedAvail Financials at a Glance

MDVLQ News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About MedAvail

MDVLQ Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

MedAvail Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MDVLQ

What is the current price of MedAvail?

What is the 52-week range for MedAvail?

How much debt does MedAvail have?

How much cash does MedAvail have on hand?

What is MedAvail’s dividend yield?

Premium Investing Services